Among the cancer-related signaling pathways, GRGs had high levels of activation in epithelial-mesenchymal transition (EMT), hormone androgen receptor (AR) and cell cycle signaling pathway (Supplementary Figure 9). The gene discussed is AR; the disease is cancer.